Final report of University Hospital Hradec Kralove to the clinical trial protocol no. AV001

Abstract

A Multicenter Phase 3 Randomized, Open-Label Study of Bosutinib versus Imatinib in Adult Patients with Newly Diagnosed Chranic Phase Chronic Myelogenous Leukemia

Keywords

• Bosutinib
• Imatinib
• Chronic Myelogenous Leukemia